UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13G

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                              (AMENDMENT NO. ____)


                         PROVECTUS PHARMACEUTICALS, INC.
--------------------------------------------------------------------------------
                                (Name of Issuer)


                          COMMON STOCK, $.001 PAR VALUE
--------------------------------------------------------------------------------
                         (Title of Class of Securities)


                                    74373F100
--------------------------------------------------------------------------------
                                 (CUSIP Number)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

|X| Rule 13d-1(c)

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

                         (Continued on following page(s)


                               Page 1 of 4 Pages


-------------------                                          -------------------
CUSIP No. 74373F100                   13G                     Page 2 of 4 Pages
-------------------                                          -------------------

--------------------------------------------------------------------------------
1.    NAMES OF REPORTING PERSON
      S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      Alpha Capital Aktiengesellschaft
--------------------------------------------------------------------------------
2.    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
                                                                         (a) |_|
                                                                         (b) |_|
--------------------------------------------------------------------------------
3.    SEC USE ONLY


--------------------------------------------------------------------------------
4.    CITIZENSHIP OR PLACE OF ORGANIZATION

      Liechtenstein
--------------------------------------------------------------------------------
5.    SOLE VOTING POWER, NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING
      PERSON

      1,166,667 Common stock
--------------------------------------------------------------------------------
6.    SHARED VOTING POWER

      None
--------------------------------------------------------------------------------
7.    SOLE DISPOSITIVE POWER

      1,166,667 shares of Common Stock
--------------------------------------------------------------------------------
8.    SHARED DISPOSITIVE POWER

      None
--------------------------------------------------------------------------------
9.    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

      1,166,667 shares of Common Stock
--------------------------------------------------------------------------------
10.   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES   |_|


--------------------------------------------------------------------------------
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

      5.8%
--------------------------------------------------------------------------------
12.   TYPE OF REPORTING PERSON

      CO
--------------------------------------------------------------------------------


-------------------                                          -------------------
CUSIP No. 74373F100                   13G                     Page 3 of 4 Pages
-------------------                                          -------------------


ITEM 1 (a)  NAME OF ISSUER:

            Provectus Pharmaceuticals, Inc.

ITEM 1 (b)  ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

            7327 Oak Ridge Highway, Suite A, Knoxville, TN 37931

ITEM 2 (a)  NAME OF PERSON FILING:

            Alpha Capital Aktiengesellschaft

ITEM 2 (b)  ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

            Pradafant 7, Furstentums 9490, Vaduz, Liechtenstein

ITEM 2 (c)  CITIZENSHIP:

            Liechtenstein

ITEM 2 (d)  TITLE OF CLASS OF SECURITIES:

            Common Stock, $.001 par value

ITEM 2 (e)  CUSIP NUMBER:

            74373F100

ITEM 3      IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B):

            Not applicable

ITEM 4      OWNERSHIP

            (a)   AMOUNT BENEFICIALLY OWNED: 1,166,667 Shares of Common Stock

            (b)   PERCENT OF CLASS: 5.8%

            (c)   NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:

                  (i)   SOLE POWER TO VOTE OR DIRECT THE VOTE

                        1,166,667 Shares

                  (ii)  SHARED POWER TO VOTE OR DIRECT THE VOTE

                        0 Shares

                  (iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

                        1,166,667 Shares

                  (iv)  SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

                        0 Shares




-------------------                                          -------------------
CUSIP No. 74373F100                   13G                     Page 4 of 4 Pages
-------------------                                          -------------------


ITEM 5      OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

            Not applicable

ITEM 6      OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

            Not applicable

ITEM 7      IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
            THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

            Not applicable

ITEM 8      IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP

            Not applicable

ITEM 9      NOTICE OF DISSOLUTION OF GROUP

            Not applicable



                                    SIGNATURE

      After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

                                          February 7, 2006
                                          --------------------------------------
                                                (Date)


                                          /s/ Konrad Ackerman
                                          --------------------------------------
                                           (Signature)

                                          Konrad Ackerman, Director
                                          --------------------------------------
                                          (Name/Title)